Pfizer (PFE) director Mortimer Buckley awarded 1,386.834 phantom units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Buckley Mortimer J reported acquisition or exercise transactions in this Form 4 filing.

Pfizer Inc. director Mortimer J. Buckley received a grant of 1,386.834 Phantom Stock Units on deferred compensation terms. Each unit represents one phantom share of common stock valued at $27.04. Following the award, Buckley holds 16,704.585 Phantom Stock Units, which will be settled in cash or stock after his retirement from the Board.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Buckley Mortimer J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	1,386.834	$27.04	$37K

Holdings After Transaction: Phantom Stock Units — 16,704.585 shares (Direct)

Footnotes (1)

Each unit represents one phantom share of common stock. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Key Figures

Phantom Stock Units granted: 1,386.834 units Unit reference price: $27.0400 per unit Total Phantom Stock Units after grant: 16,704.585 units

3 metrics

Phantom Stock Units granted 1,386.834 units Grant on March 27, 2026

Unit reference price $27.0400 per unit Value used for this phantom grant

Total Phantom Stock Units after grant 16,704.585 units Holdings following the reported transaction

Key Terms

Phantom Stock Units, deferred director's compensation, dividend equivalents

3 terms

Phantom Stock Units financial

"security_title: "Phantom Stock Units" and footnote "Each unit represents one phantom share of common stock.""

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

deferred director's compensation financial

"These units represent deferred director's compensation (including dividend equivalents thereon)..."

dividend equivalents financial

"deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock..."

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

Form 4 Insider Transactions: What Each Field Means →

03/30/2026 - 08:18 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buckley Mortimer J

(Last)

(First)

(Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK

10001-2192

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Phantom Stock Units	⁽¹⁾	03/27/2026		A		1,386.834		⁽²⁾	⁽²⁾	Common Stock	1,386.834	$27.04	16,704.585	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

	/s/ Shanice A. Reid, by power of atty., for Mortimer J. Buckley	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Pfizer (PFE) director Mortimer Buckley report?

Pfizer director Mortimer J. Buckley reported receiving 1,386.834 Phantom Stock Units as a grant. These units are part of his deferred director compensation and are linked to Pfizer common stock value, but will be settled later rather than immediately in shares or cash.

How many Pfizer Phantom Stock Units does Mortimer Buckley hold after this Form 4?

After the reported grant, Mortimer J. Buckley holds 16,704.585 Phantom Stock Units. This total reflects his deferred director compensation balance, including dividend equivalents, and represents a cash- or stock-settled obligation payable after he retires from Pfizer’s Board of Directors.

What are Phantom Stock Units in the Pfizer (PFE) director’s compensation plan?

Phantom Stock Units are bookkeeping units, each representing one phantom share of Pfizer common stock. They track the stock’s value and may accumulate dividend equivalents, but are ultimately settled in cash or shares according to the plan terms instead of being actual current stock ownership.

When will Mortimer Buckley’s Pfizer Phantom Stock Units be settled?

Buckley’s Phantom Stock Units will be settled following his retirement from Pfizer’s Board of Directors. At that time, they will be paid in either cash or common stock, according to his election and the terms of the company’s deferred director compensation program.

Is Mortimer Buckley’s Pfizer Form 4 transaction a stock purchase or sale?

The Form 4 reports a grant of 1,386.834 Phantom Stock Units, not an open-market stock purchase or sale. It reflects deferred director compensation rather than a discretionary trade in Pfizer common shares on the public market by Mortimer J. Buckley.